Gut hormones may control blood flow to bones, new study hints
NCT ID NCT07679516
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study investigates whether natural gut hormones—GIP, GLP-2, and amylin—can change how much blood flows to the bones. Fifteen healthy adults aged 25 to 50 will receive infusions of each hormone separately, and a placebo, while researchers measure bone blood flow using advanced imaging. The goal is to understand basic bone physiology, which could eventually inform treatments for bone conditions like osteoporosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GIP, GLP-2, and amylin (as infusions)
What this could lead to
If these hormones are found to regulate bone blood flow, it could point toward new ways to treat or prevent bone diseases like osteoporosis.
What could go wrong
This is a very small, early study in healthy people, so results may not apply to those with bone conditions. It only measures short-term effects, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rigshospitalet
Copenhagen, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••